Your browser doesn't support javascript.
loading
Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020
Clèries, R; Rooney, RM; Vilardell, M; Espinàs, JA; Dyba, T; Borras, JM.
Afiliação
  • Clèries, R; Instituto de Investigación Biomédica de Bellvitge (IDIBELL). Catalan Cancer Plan. Barcelona. Spain
  • Rooney, RM; Institute for Health and Consumer Protection. DG Joint Research Centre. European Commission. Ispra. Italy
  • Vilardell, M; University of Barcelona. Microbiology and Statistics, Biology Faculty. Department of Genetics. Section Statistics. Barcelona. Spain
  • Espinàs, JA; Instituto de Investigación Biomédica de Bellvitge (IDIBELL). Catalan Cancer Plan. Barcelona. Spain
  • Dyba, T; Institute for Health and Consumer Protection. DG Joint Research Centre. European Commission. Ispra. Italy
  • Borras, JM; Instituto de Investigación Biomédica de Bellvitge (IDIBELL). Catalan Cancer Plan. Barcelona. Spain
Clin. transl. oncol. (Print) ; 20(3): 313-321, mar. 2018. tab, ilus
Artigo em Inglês | IBECS | ID: ibc-171318
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
Background. We assessed differences in predicted breast cancer (BC) mortality rates, across Europe, by 2020, taking into account changes in the time trends of BC mortality rates during the period 2000-2010. Methods. BC mortality data, for 27 European Union (EU) countries, were extracted from the World Health Organization mortality database. First, we compared BC mortality data between time periods 2000-2004 and 2006-2010 through standardized mortality ratios (SMRs) and carrying out a graphical assessment of the age-specific rates. Second, making use of the base period 2006-2012, we predicted BC mortality rates by 2020. Finally, making use of the SMRs and the predicted data, we identified a clustering of countries, assessing differences in the time trends between the areas defined in this clustering. Results. The clustering approach identified two clusters of countries the first cluster were countries where BC predicted mortality rates, in 2020, might slightly increase among women aged 69 and older compared with 2010 [Greece (SMR 1.01), Croatia (SMR 1.02), Latvia (SMR 1.15), Poland (SMR 1.14), Estonia (SMR 1.16), Bulgaria (SMR 1.13), Lithuania (SMR 1.03), Romania (SMR 1.13) and Slovakia (SMR 1.06)]. The second cluster was those countries where BC mortality rates level off or decrease in all age groups (remaining countries). However, BC mortality rates between these clusters might diminish and converge to similar figures by 2020. Conclusions. For the year 2020, our predictions have shown a converging pattern of BC mortality rates between European regions. Reducing disparities, in access to screening and treatment, could have a substantial effect in countries where a non-decreasing trend in age-specific BC mortality rates has been predicted (AU)
RESUMEN
No disponible
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Contexto em Saúde: ODS3 - Saúde e Bem-Estar / ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis Problema de saúde: Meta 3.8 Atingir a cobertura universal de saúde / Neoplasia da Mama Base de dados: IBECS Assunto principal: Neoplasias da Mama / Indicadores de Morbimortalidade Tipo de estudo: Estudo diagnóstico / Estudo prognóstico / Fatores de risco / Estudo de rastreamento Limite: Feminino / Humanos Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2018 Tipo de documento: Artigo Instituição/País de afiliação: Institute for Health and Consumer Protection/Italy / Instituto de Investigación Biomédica de Bellvitge (IDIBELL)/Spain / University of Barcelona/Spain
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Contexto em Saúde: ODS3 - Saúde e Bem-Estar / ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis Problema de saúde: Meta 3.8 Atingir a cobertura universal de saúde / Neoplasia da Mama Base de dados: IBECS Assunto principal: Neoplasias da Mama / Indicadores de Morbimortalidade Tipo de estudo: Estudo diagnóstico / Estudo prognóstico / Fatores de risco / Estudo de rastreamento Limite: Feminino / Humanos Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2018 Tipo de documento: Artigo Instituição/País de afiliação: Institute for Health and Consumer Protection/Italy / Instituto de Investigación Biomédica de Bellvitge (IDIBELL)/Spain / University of Barcelona/Spain
...